Investigational product (IP)

DRUG2 trials

Sponsors

Société des Produits Nestlé (SPN), Ruijin Hospital

Conditions

HealthyLymphoma, B-Cell Refractory

Phase 1

Exploration of Circular RNA in B-cell Hematologic Malignancies

RecruitingNCT07774572

Ruijin HospitalLymphoma, B-Cell Refractory

Start: 2026-05-26End: 2029-03-01Target: 30Updated: 2026-08-19

Unknown Phase

Effects of Low Lactose Milk Containing GOS on Digestive Response in Healthy Chinese Adults

CompletedNCT06598124

Société des Produits Nestlé (SPN)Healthy

Start: 2024-08-20End: 2025-06-30Updated: 2025-11-24